Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the management of type 2 diabetes mellitus and, in specific cases, for weight management
Stay on track with your weight management and performance goals, all while indulging in refreshing, delicious flavors that make staying fit feel like a treat
Moreover, long-term observational studies and real-world evidence are needed to assess the durability of treatment response, long-term safety, and impact on clinical outcomes, such as lupus flares, organ damage, and quality of life
It is manufactured by Eli Lilly and currently holds FDA approval under two brand names: Mounjaro for type 2 diabetes management and Zepbound for chronic weight management
US$ 28.65
US$ 29.88
US$ 20.32
US$ 27.18
US$ 29.43
US$ 27.12
US$ 28.46
US$ 22.50
US$ 25.14
US$ 22.35
US$ 28.60
